THU296 Effect Of Tirzepatide In GADA-positive Individuals With T2D: A Post Hoc Analysis Of The SURPASS 2-5 Trials

Disclosure: A.L. Peters: Advisory Board Member; Self; Abbott Diabetes Care, Eli Lilly & Company, Medscape, Novo Nordisk, Zealand. Grant Recipient; Self; Dexcom, Insulet Corporation. Stock Owner; Self; Omada Health, Teladoc. Other; Self; Abbott Diabetes Care. R. Buzzetti: Consulting Fee; Self; Sa...

Descripción completa

Detalles Bibliográficos
Autores principales: Peters, Anne L, Buzzetti, Raffaella, Eun Lee, Clare Jung, Pavo, Imre, Liu, Minzhi, Paik, Jim S
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2023
Materias:
Diabetes And Glucose Metabolism
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10555850/
http://dx.doi.org/10.1210/jendso/bvad114.731

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10555850/
http://dx.doi.org/10.1210/jendso/bvad114.731

Ejemplares similares